Rani Therapeutics Holdings Inc (RANI) - News Archive

SAN JOSE, Calif., Oct. 17, 2025 Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a pioneering clinical-stage biotherapeutics company dedicated to the oral delivery of biologics and pharmaceuticals, has officially announ...

In the ever-evolving landscape of biotherapeutics, Rani Therapeutics Holdings, Inc. stands out as a pioneer dedicated to advancing the oral delivery of biologics and pharmaceuticals. As a clinical-stage company, Rani is...

Rani Therapeutics Raises $10 Million in Registered Direct OfferingSAN JOSE, Calif., July 22, 2024 - Rani Therapeutics Holdings, Inc. (Nasdaq: RANI) announced today the pricing of a $10.0 million registered direct offeri...

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity TreatmentIn an exciting development for the pharmaceutical industry, Rani Therapeutics has announced a partnership with ProGen to collab...

Rani Therapeutics Holdings, Inc. (Rani Therapeutics) has recently announced its plan to present groundbreaking clinical and preclinical data on the RaniPill capsule at Digestive Disease Week (DDW) 2024. As a clinical-st...

In a significant advancement in oral drug delivery, Rani Therapeutics, a pioneer in oral biologics, has revealed compelling preclinical pharmacodynamic data on the transenteric delivery of GLP-1 Incretin Triagonist. Thi...